# Single and Multiple Dose Study of VER-01 in Healthy Volunteers

> **NCT04930809** · PHASE1 · COMPLETED · sponsor: **Vertanical GmbH** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** VER-01

## Key facts

- **NCT ID:** NCT04930809
- **Lead sponsor:** Vertanical GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-25
- **Primary completion:** 2022-07-04
- **Final completion:** 2022-07-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930809, "Single and Multiple Dose Study of VER-01 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04930809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*